Pfizer shares experienced a healthy 7.71% gain today as the company announced a patent victory on its biggest selling drug. This stock is technically interesting because it gapped up toward the combined resistance of the October highs and the 200 DMA. These levels have prevented the bulls from pushing the price higher on several previous occasions, and we believe that this may be the case again.



PFE_121905.jpg

You May Also Like

Related Analysis
  1. Stock Analysis

    Guess Who Won a $900 Million Defense Contract?

  2. Stock Analysis

    Teva Pharma to Acquire Allergan: Analysts Weigh In

  3. Stock Analysis

    Here's Why Analysts Bullish On Skyworks Solutions

  4. Investing Basics

    Is Divestment Destroying The Coal Industry?

  5. Trading Strategies

    IPO Flippers And The Companies Who Hate Them

Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!